Live Feeds
● LIVE Updated 1h ago · 14 sources tracked

Groundbreaking Copper Drug Could Boost Memory by 44 Percent, a Breakthrough in Treating Cognitive Decline

Monash University researchers found that the copper-based compound Cu(ATSM) restores the brain's ability to clear toxic proteins. Laboratory experiments show the drug reduces amyloid buildup and improves spatial memory. The compound has previously been tested in humans for other neurological conditions.

RSS Source map (14)

What changed

New data specifies the drug's impact on P-gp pumps, amyloid-beta levels, and spatial memory percentages.

Live updates

  1. Copper Drug Cu(ATSM) Reduces Alzheimer's Proteins and Improves Memory

    Monash University researchers found that the copper-based compound Cu(ATSM) restores the brain's ability to clear toxic proteins. Laboratory experiments show the drug reduces amyloid buildup and improves spatial memory. The compound has previously been tested in humans for other neurological conditions.

    What's confirmed:

    • The copper-based compound Cu(ATSM) reduced amyloid-beta by 42%
    • Cu(ATSM) improved spatial memory by 44% in Alzheimer's models
    • The drug increased the brain's P-gp pumps by 24%
    • Cu(ATSM) has already been tested in humans for other neurological conditions
    • Research from Monash University was published in ACS Chemical Neuroscience on June 15, 2026
    confidence 100%